Back to Journals » OncoTargets and Therapy » Volume 12

Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy

Total article views   HTML views PDF downloads Totals
6,110 Dovepress* 4,879+ 1,057 5,936
PubMed Central* 1,231 490 1,721
Totals 6,110 1,547 7,657
*Since 27 November 2019
Total mentioned Facebook Delicious Reddit Twitter Others
12 0 0 0 6 6

View citations on PubMed Central and Google Scholar